Elisabeth Hofmeister

Elisabeth Hofmeister is a Doctoral Student and Junior Research Fellow at the Max Planck Institute for Innovation and Competition, focusing on Innovation and Entrepreneurship Research, while concurrently pursuing postgraduate studies in Business Research at LMU Munich's Munich School of Management.

Her academic training includes:

• Postgraduate Studies in Business Research (MBR) at LMU Munich (since 04/2022)
• M.Sc. in Management & Technology (Chemistry major) from TUM (09/2018–09/2021)
• B.Sc. in Management & Technology (Chemistry minor) from TUM (09/2014–09/2018)

Hofmeister's research spans Innovation Economics, Industrial Organization, Competition Economics, and Health Economics, with emphasis on regulatory frameworks for biotechnology and pharmaceutical innovation. She investigates how patent systems, trade regulations, and market structures influence innovation diffusion, particularly in genome-edited products and shelved pharmaceutical projects.

Her publications analyze critical tensions between intellectual property protection and innovation access, revealing systemic bottlenecks in biotechnology commercialization. Recent work demonstrates how divergent global regulations on genome-edited foods create WTO compliance risks and how CRISPR patent landscapes may stifle cumulative innovation.

Key recognition:

• TUM Finance and Accounting Selected Talents (TUMfast) scholarship (since 10/2018)

Hofmeister actively disseminates findings through seminars at the Max Planck Institute and international forums like Boston University, contributing to policy debates on innovation governance within the Innovation and Entrepreneurship Research group.